Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
DRREDDY-ANSE
MANKIND-ANSE
MAKERSL-BNSE
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 15% | 12% | 16% |
| - | - | - | -28% |
| - | -2% | 22% | 33% |
| 7% | 7% | 7% | 11% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
AUROPHARMA-A
LUPIN-A
DRREDDY-A
MANKIND-A
MAKERSL-B
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,868 | ₹440398 Cr | 36.41 | 12.07 | 62.82 | ₹11479 Cr |
| 9,432 | ₹248664 Cr | 85.01 | 34.04 | 128.41 | ₹2568 Cr |
| 4,968 | ₹182738 Cr | 83.79 | 16.72 | 97.06 | ₹2163 Cr |
| 1,161.5 | ₹115012 Cr | 25.48 | 9.42 | 62.53 | ₹5040 Cr |
| 1,385 | ₹110794 Cr | 32.87 | 9.77 | 57.87 | ₹3879 Cr |
| 2,018 | ₹105645 Cr | 96.62 | 6.8 | 29.25 | ₹889 Cr |
| 1,717.2 | ₹99828 Cr | 26.89 | 17.95 | 96.84 | ₹3505 Cr |
| 2,120 | ₹98070 Cr | 17.74 | 30.95 | 154.36 | ₹5333 Cr |
| 1,202 | ₹97749 Cr | 30.34 | 5.32 | 63.99 | ₹4196 Cr |
| 2,429.85 | ₹95744 Cr | 46.87 | 13.75 | 71.08 | ₹1913 Cr |
| 189.05 | ₹113 Cr | 32.93 | 2.55 | 13.48 | ₹2 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹43 Cr | ₹36 Cr | ₹36 Cr | ₹34 Cr | ₹35 Cr | ₹34 Cr | ₹28 Cr | ₹30 Cr | ₹30 Cr | ₹28 Cr | ₹27 Cr | ₹25 Cr | ₹25 Cr | ₹29 Cr | ₹20 Cr | ₹27 Cr | ₹25 Cr | ₹27 Cr | ₹29 Cr | ₹34 Cr | ₹36 Cr | ₹31 Cr | ₹15 Cr |
| ₹61 L | ₹76 L | ₹33 L | ₹36 L | ₹27 L | ₹12 L | ₹88 L | ₹11 Cr | ₹38 L | ₹43 L | ₹37 L | ₹41 L | ₹25 L | ₹12 L | ₹27 L | ₹88 L | ₹1 Cr | ₹65 L | ₹1 Cr | ₹58 L | ₹59 L | ₹34 L | ₹31 L |
| ₹43 Cr | ₹37 Cr | ₹36 Cr | ₹35 Cr | ₹35 Cr | ₹34 Cr | ₹29 Cr | ₹40 Cr | ₹30 Cr | ₹28 Cr | ₹27 Cr | ₹25 Cr | ₹25 Cr | ₹30 Cr | ₹20 Cr | ₹27 Cr | ₹26 Cr | ₹28 Cr | ₹31 Cr | ₹34 Cr | ₹37 Cr | ₹31 Cr | ₹15 Cr |
| ₹37 Cr | ₹32 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹32 Cr | ₹28 Cr | ₹29 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹29 Cr | ₹21 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹29 Cr | ₹32 Cr | ₹28 Cr | ₹16 Cr |
| ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹13 Cr | ₹2 Cr | ₹1 Cr | ₹57 L | ₹61 L | ₹12 L | ₹2 Cr | ₹9 L | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹79 L |
| ₹15 L | ₹17 L | ₹20 L | ₹22 L | ₹18 L | ₹18 L | ₹19 L | ₹43 L | ₹49 L | ₹52 L | ₹53 L | ₹49 L | ₹41 L | ₹25 L | ₹42 L | ₹1 Cr | ₹39 L | ₹41 L | ₹39 L | ₹50 L | ₹43 L | ₹58 L | ₹41 L |
| ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹68 L | ₹11 Cr | -₹47 L | -₹38 L | -₹1 Cr | -₹1 Cr | -₹1 Cr | ₹53 L | -₹2 Cr | ₹41 L | -₹26 L | ₹1 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | -₹78 L |
| ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹75 L | ₹1 Cr | ₹2 Cr | ₹27 L | ₹10 Cr | -₹70 L | -₹96 L | -₹1 Cr | -₹1 Cr | -₹2 Cr | ₹35 L | -₹2 Cr | ₹7 L | -₹83 L | ₹93 L | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹1 Cr | -₹1 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr |
| ₹67 Cr | ₹65 Cr | ₹57 Cr | ₹63 Cr | ₹55 Cr | ₹49 Cr |
| ₹67 Cr | ₹65 Cr | ₹57 Cr | ₹63 Cr | ₹55 Cr | ₹49 Cr |
| ₹73 Cr | ₹71 Cr | ₹63 Cr | ₹69 Cr | ₹60 Cr | ₹54 Cr |
| ₹50 Cr | ₹45 Cr | ₹41 Cr | ₹40 Cr | ₹39 Cr | ₹32 Cr |
| ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹6 Cr |
| ₹0 | ₹0 | ₹6 Cr | ₹2 Cr | ₹0 | ₹0 |
| ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
| ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| ₹42 L | ₹27 L | ₹25 L | ₹27 L | ₹43 L | ₹38 L |
| ₹10 Cr | ₹12 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr | ₹16 Cr |
| — | — | — | — | — | — |
| ₹20 Cr | ₹12 Cr | ₹17 Cr | ₹10 Cr | ₹5 Cr | ₹15 Cr |
| ₹10 Cr | ₹8 Cr | ₹12 Cr | ₹11 Cr | ₹14 Cr | ₹9 Cr |
| ₹3 Cr | ₹30 L | ₹7 Cr | ₹5 Cr | ₹12 Cr | ₹6 Cr |
| ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
| ₹34 Cr | ₹21 Cr | ₹37 Cr | ₹28 Cr | ₹33 Cr | ₹33 Cr |
| ₹167 Cr | ₹148 Cr | ₹161 Cr | ₹152 Cr | ₹144 Cr | ₹136 Cr |
| ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr |
| ₹5 Cr | ₹3 Cr | ₹18 Cr | ₹11 Cr | ₹17 Cr | ₹14 Cr |
| — | — | — | — | — | — |
| ₹120 Cr | ₹119 Cr | ₹136 Cr | ₹130 Cr | ₹110 Cr | ₹82 Cr |
| ₹50 Cr | ₹45 Cr | ₹49 Cr | ₹45 Cr | ₹42 Cr | ₹11 Cr |
| ₹71 Cr | ₹74 Cr | ₹87 Cr | ₹85 Cr | ₹68 Cr | ₹71 Cr |
| ₹4 Cr | ₹59 L | ₹32 L | ₹45 L | ₹9 Cr | ₹16 L |
| ₹15 L | ₹14 L | ₹12 L | ₹8 L | ₹22 L | ₹1 Cr |
| ₹15 L | ₹14 L | ₹12 L | ₹8 L | ₹22 L | ₹1 Cr |
| ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
| ₹5 L | ₹11 L | ₹6 L | ₹5 L | ₹53 L | ₹56 L |
| ₹80 Cr | ₹80 Cr | ₹91 Cr | ₹89 Cr | ₹81 Cr | ₹75 Cr |
| — | — | — | — | — | — |
| ₹12 Cr | ₹0 | ₹3 Cr | ₹0 | ₹0 | ₹75 L |
| ₹45 Cr | ₹34 Cr | ₹34 Cr | ₹31 Cr | ₹24 Cr | ₹27 Cr |
| ₹20 Cr | ₹28 Cr | ₹20 Cr | ₹20 Cr | ₹14 Cr | ₹17 Cr |
| ₹63 L | ₹65 L | ₹2 Cr | ₹4 Cr | ₹9 Cr | ₹6 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹88 L | ₹4 Cr | ₹9 Cr |
| ₹9 Cr | ₹4 Cr | ₹10 Cr | ₹7 Cr | ₹13 Cr | ₹1 Cr |
| ₹87 Cr | ₹68 Cr | ₹70 Cr | ₹63 Cr | ₹63 Cr | ₹61 Cr |
| ₹53 Cr | ₹47 Cr | ₹33 Cr | ₹36 Cr | ₹30 Cr | ₹28 Cr |
| ₹167 Cr | ₹148 Cr | ₹161 Cr | ₹152 Cr | ₹144 Cr | ₹136 Cr |
| ₹124 | ₹119 | ₹107 | ₹117 | ₹121 | ₹110 |
| ₹124 | ₹119 | ₹107 | ₹117 | ₹121 | ₹106 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹11 Cr | ₹13 Cr | -₹4 Cr | -₹84 L | ₹16 Cr | ₹0 |
| ₹5 Cr | -₹4 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹0 |
| ₹2 Cr | -₹11 Cr | ₹74 L | -₹11 Cr | ₹3 Cr | ₹0 |
| ₹18 Cr | -₹2 Cr | ₹3 Cr | -₹6 Cr | ₹24 Cr | ₹0 |
| ₹14 Cr | -₹4 Cr | ₹84 L | -₹9 Cr | ₹18 Cr | ₹0 |
| -₹15 Cr | ₹20 Cr | -₹7 Cr | ₹1 Cr | -₹22 Cr | ₹0 |
| ₹35 L | -₹16 Cr | ₹6 Cr | ₹6 Cr | ₹33 L | ₹0 |
| -₹5 L | -₹17 L | -₹31 L | -₹2 Cr | -₹3 Cr | ₹0 |
| ₹24 L | ₹41 L | ₹72 L | ₹2 Cr | ₹5 Cr | ₹0 |
| ₹20 L | ₹24 L | ₹41 L | ₹72 L | ₹2 Cr | ₹0 |
Fundamental Ratios
Consolidated
Standalone

No results found
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
54.14Neutral
STOCH %K
38.82Neutral
MACD Level(12,26)
2.99Buy
Ultimate Oscillator
46.24Sell
Aroon Oscillator
64.00Buy
BOP
-0.89Sell
CCI
-5.02Neutral
Williams %R
-61.18Neutral
Momentum
-6.70Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
184.55Buy
SMA 9
183.63Buy
EMA 21
183.40Buy
SMA 21
191.04Sell
EMA 50
174.43Buy
SMA 50
170.04Buy
EMA 200
155.89Buy
SMA 200
147.93Buy
WMA 20
187.04Buy
Pivot
Pivot
Classic
Resistance 5
222.32
Resistance 4
212.32
Resistance 3
202.32
Resistance 2
192.32
Resistance 1
188.63
Pivot
182.32
Support 1
178.63
Support 2
172.32
Support 3
162.32
Support 4
152.32
Support 5
142.32
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 38.73% | 38.73% | 38.73% | 38.73% | 38.73% | 38.73% |
Bulk & block deals
Name
Usha Jawaharlal Kalro
Usha Jawaharlal Kalro
Manju Singhi
Vinar Niryat Private Limited
Vara Lakshmi G
Neelima Karlapudi
Usha Ashok Samani
Guttikonda Vara Lakshmi
Nanda Devi Investments
Guttikonda Vara Lakshmi
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 20 May 2026 | Purchase | 53.73 L | ₹173.27 | 31.01 K | Bulk | 0.525541 | BSE |
| 20 May 2026 | Sell | 47.15 L | ₹180.25 | 26.16 K | Bulk | 0.443326 | BSE |
| 13 Mar 2023 | Sell | 31.26 L | ₹105.75 | 29.56 K | Bulk | 0.501017 | BSE |
| 23 Nov 2020 | Purchase | 64.18 L | ₹138.76 | 46.25 K | Bulk | 0.783845 | BSE |
| 23 Nov 2020 | Sell | 82.51 L | ₹139.50 | 59.15 K | Bulk | 1.002457 | BSE |
| 06 Oct 2020 | Sell | 48.68 L | ₹96.90 | 50.24 K | Bulk | 0.8514 | BSE |
| 12 Aug 2020 | Purchase | 21.81 L | ₹72.70 | 30 K | Bulk | 0.50844 | BSE |
| 03 Aug 2020 | Sell | 19.80 L | ₹79.23 | 24.99 K | Bulk | 0.423548 | BSE |
| 08 Apr 2020 | Sell | 10.38 L | ₹39.95 | 25.98 K | Bulk | 0.440258 | BSE |
| 21 Sep 2018 | Purchase | 30.48 L | ₹99.04 | 30.77 K | Bulk | 0.521507 | BSE |
Insider trading & SAST
Client name
Kaygee Investments Pvt Ltd & Pacs
Paschim Chemicals Pvt. Ltd.
Kaygee Investments Pvt. Ltd.
Mexin Medicaments Pvt. Ltd.
Premchand Godha & Others
Chandurkar Investments Pvt. Ltd.
Mexin Medicaments Pvt. Ltd.
Kaygee Laboratories Pvt. Ltd.
Paschim Chemicals Pvt. Ltd.
Kaygee Investments Pvt. Ltd.
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18 Sep 2025 | Promoter | Acquisition | 19.5 | 36.88 | 0 | — | 11.51 L | 20 Aug 2025 | Merger | 21,75,859 | SAST | 29(2) | — |
| 21 Aug 2025 | Promoter Group | Disposal | 16.38316 | 0 | 0 | — | 9.67 L | 20 Aug 2025 | Others | 0 | Insider Trading | — | Equity Shares |
| 21 Aug 2025 | Promoter Group | Acquisition | 19.500017 | 36.88 | 0 | — | 11.51 L | 20 Aug 2025 | Others | 21,75,859 | Insider Trading | — | Equity Shares |
| 21 Aug 2025 | Promoter Group | Disposal | 3.116856 | 0 | 0 | — | 1.84 L | 20 Aug 2025 | Others | 0 | Insider Trading | — | Equity Shares |
| 11 May 2022 | Promoter | Acquisition | 12.63 | 61.28 | 0 | — | 7.45 L | 09 May 2022 | Rights Issue | 36,15,356 | SAST | 29(2) | — |
| 10 May 2022 | Promoter Group | Acquisition | 0.398841 | 1.43 | 29.42 L | ₹150 | 19.61 K | 09 May 2022 | Allotment | 84,411 | Insider Trading | — | Equity Shares |
| 10 May 2022 | Promoter Group | Acquisition | 0.868965 | 3.12 | 64.09 L | ₹150 | 42.73 K | 09 May 2022 | Allotment | 1,83,907 | Insider Trading | — | Equity Shares |
| 10 May 2022 | Promoter Group | Acquisition | 4.000814 | 14.35 | 2.95 Cr | ₹150 | 1.97 L | 09 May 2022 | Allotment | 8,46,720 | Insider Trading | — | Equity Shares |
| 10 May 2022 | Promoter Group | Acquisition | 4.067521 | 16.38 | 3 Cr | ₹150 | 2 L | 09 May 2022 | Allotment | 9,66,672 | Insider Trading | — | Equity Shares |
| 10 May 2022 | Promoter Group | Acquisition | 3.47529 | 17.38 | 2.56 Cr | ₹150 | 1.71 L | 09 May 2022 | Allotment | 10,25,280 | Insider Trading | — | Equity Shares |
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Makers Laboratories Ltd is engaged in manufacturing pharmaceutical formulations and drug intermediaries.The product portfolio of the company includes Tablets & Capsules Liquids (Oral) Injectables Drugs (Intermediates)and Creams & Ointments.
Corporate Actions
Date
Type
Details
Company details
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Makers Laboratories Share Price
189.05+0.00 (+2.22%)
+33.46% past 1 Year
News
Makers Laboratories informs about newspaper publication
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories reports Profit after tax of Rs -96.40 Lakhs, in the March 2026 quarter
Equity
MAKERSL
Makers Laboratories informs about newspaper publication
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories reports Profit after tax of Rs -17.40 Lakhs, in the December 2025 quarter
Equity
MAKERSL
Makers Laboratories submits board meeting intimation
Equity
MAKERSL
Makers Laboratories informs about press release
Equity
MAKERSL
Makers Laboratories informs about newspaper publication
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories reports Profit after tax of Rs -31.20 Lakhs, in the September 2025 quarter
Equity
MAKERSL
Makers Laboratories informs about newspaper advertisement
Equity
MAKERSL
Makers Laboratories informs about credit rating
Equity
MAKERSL
Makers Laboratories informs about newspapers publication
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories reports Profit after tax of Rs -27.10 Lakhs, in the June 2025 quarter
Equity
MAKERSL
Makers Laboratories - Quaterly Results
Equity
MAKERSL
Makers Laboratories informs about board meeting
Equity
MAKERSL
Makers Laboratories informs about annual report
Equity
MAKERSL

